您当前的位置：
首页 >
文章列表页 >
Research progress on the role and mechanism of IRAK4 in hematological malignancies
Medical Journal of Chinese People′s Liberation Army   Vol. 49, Issue 9, Pages: 1094-1098(2024)
Review | 更新时间：2024-10-10
|

    • Research progress on the role and mechanism of IRAK4 in hematological malignancies

    • “在血液系统恶性肿瘤治疗领域，IRAK4作为关键信号转导分子，为疾病发生机制和靶向治疗研究提供新思路。”

    • DOI：10.11855/j.issn.0577-7402.1579.2024.0418    

      CLC： R733

    • Published：28 September 2024，

      Published Online：2024-18-04，

      Received：29 November 2023，

      Accepted：22 March 2024

    移动端阅览

  • Shang Ying,Li Li-Juan,Zhang Lian-Sheng.Research progress on the role and mechanism of IRAK4 in hematological malignancies[J].Medical Journal of Chinese People′s Liberation Army,2024,49(09):1094-1098. DOI： 10.11855/j.issn.0577-7402.1579.2024.0418.

  •  
  •  

0

Views

0

下载量

0

CSCD

0

CNKI被引量

>
Alert me when the article has been cited
提交
Outline
No Sections

Related Articles

Research progress on acquired RET fusion induces secondary resistance to EGFR therapy in advanced EGFR-mutated non-small cell lung cancer
Research progress of vitamin D in neuro-developmental disabilities
Research progress on cholesterol metabolism in the regulation of colorectal cancer
Research progress on pathogenesis and treatment of diabetes cardiomyopathy

Related Author

Wang An
Li Tao
Lu Di
Mao Yun-Ye
Qin Jia-Pei
Zhou Xin
Fan Hao
Hu Yi

Related Institution

Department of Oncology, the First Medical Center, Chinese PLA General Hospital
Graduate School, Chinese PLA General Hospital/Medical School of Chinese PLA
Department of Child Rehabilitation, the Third Affiliated Hospital of Zhengzhou University/Henan Clinical Medical Research Center for Pediatric Diseases
Department of General Surgery, Lanzhou University Second Hospital
Medical Imaging of Xi'an Medical University
0